Institutional Shareholder Services is recommending Pfizer's investors to reject a management proposal on annual compensation ...

Pfizer PFE announced that the European Commission (“EC”) has granted marketing authorization to expand the use of its RSV ...

According to TipRanks.com, Schwartz is a 4-star analyst with an average return of 7.2% and a 40.2% success rate. Schwartz covers the Healthcare sector, focusing on stocks such as Crinetics ...

S&P 500, Alphabet Inc Class A, Pfizer Inc, Healthcare Realty Trust Incorporated. Read 's Market Analysis on Investing.com UK.

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

Seriously, there are several great ultra-high-yield dividend stocks to buy in April. These three especially stand out. Where to invest $1,000 right now? Our analyst team just revealed what they ...

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing authorization for ABRYSVO®, the company’s bivalent respiratory syncytial virus ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

Oldham has been ‘left in uncertainty’ since voting to withdraw from a controversial housing scheme. Councillors say they’ve heard nothing but ‘deafening silence’ from the government and Greater ...

Pfizer's stock is cheap but faces operational challenges. Analyze its valuation and performance to make informed investment ...